Alzheimer's disease (AD) is characterized by the accumulation of beta‐amyloid (Aβ), tau, microglial activation, metabolic brain changes, neurodegeneration, and cognitive decline (Jack et al, 2018). This evidence concerns the gene MAPT and Alzheimer disease.